105
Participants
Start Date
June 2, 2025
Primary Completion Date
February 29, 2028
Study Completion Date
February 29, 2028
ORC-13661
High-dose intervention (30mg daily)
ORC-13661
Low-dose intervention (12mg daily)
Placebo
Placebo intervention
NOT_YET_RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Mayo Clinic, Rochester
RECRUITING
University of Texas Health Science Center, Tyler
RECRUITING
National Jewish Health, Denver
RECRUITING
Oregon Health & Science University, Portland
Collaborators (2)
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
National Center for Advancing Translational Sciences (NCATS)
NIH
Oricula Therapeutics
UNKNOWN
University of Washington
OTHER
National Jewish Health
OTHER
Mayo Clinic
OTHER
The University of Texas Health Science Center at Tyler
OTHER
Medical University of South Carolina
OTHER
Kevin Winthrop
OTHER